SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,214 | -3.5% | 443 | +5.2% | 0.00% | – |
| Q2 2023 | $12,655 | -22.9% | 421 | -7.1% | 0.00% | – |
| Q1 2023 | $16,412 | +1.1% | 453 | -0.4% | 0.00% | – |
| Q4 2022 | $16,230 | +8.2% | 455 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $15,000 | +66.7% | 455 | +54.2% | 0.00% | – |
| Q2 2022 | $9,000 | 0.0% | 295 | +1.4% | 0.00% | – |
| Q1 2022 | $9,000 | +12.5% | 291 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | 0.0% | 291 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | -11.1% | 291 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | +12.5% | 291 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | +14.3% | 291 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | 0.0% | 291 | -10.5% | 0.00% | – |
| Q3 2020 | $7,000 | +133.3% | 325 | +155.9% | 0.00% | – |
| Q2 2020 | $3,000 | – | 127 | +568.4% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 19 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |